Sensei Biotherapeutics, Inc.(SNSE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SNSE Sensei Biotherapeutics, Inc.

盘后交易 06-17 19:28:48 EDT

13.85

+0.00

0.00%

最高13.85	最低13.85	成交量0.00
今开13.85	昨收13.85	日振幅0.00%
总市值1,856万	流通市值1,123万	总股本134.03万
成交额0.00	换手率0.00%	流通股本81.09万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SNSE","market":"US","secType":"STK","nameCN":"Sensei Biotherapeutics, Inc.","latestPrice":13.85,"timestamp":1781726400000,"preClose":13.85,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":810900,"shares":1340300,"eps":-142.7282,"marketStatus":"盘后交易","change":0,"latestTime":"06-17 19:28:48 EDT","open":13.85,"high":13.85,"low":13.85,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-142.7282,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1781740800000},"marketStatusCode":4,"symbolChange":{"newSymbol":"FTH","executeDate":"2026-06-16"},"adr":0,"listingDate":1612414800000,"exchange":"NASDAQ","adjPreClose":13.85,"volumeRatio":0},"requestUrl":"/m/hq/s/SNSE/tweets","defaultTab":"tweets","newsList":[{"id":"1155638133","title":"Sensei Biotherapeutics：Piktor治疗HR+/HER2-晚期乳腺癌的1B/2期中期数据预计2027年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1155638133","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155638133?lang=zh_cn&edition=full","pubTime":"2026-06-15 20:12","pubTimestamp":1781525543,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics公司宣布，其候选疗法Piktor针对HR阳性、HER2阴性晚期乳腺癌的1B/2期临床试验中期数据，预计将于2027年获得。该数据将提供关于疗法安全性及初步疗效的关键见解。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNSE","FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197135575","title":"Sensei Biotherapeutics：Piktor治疗晚期子宫内膜癌的II期关键数据预计2026年下半年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1197135575","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197135575?lang=zh_cn&edition=full","pubTime":"2026-06-15 20:12","pubTimestamp":1781525543,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics公司宣布，其候选药物Piktor针对晚期子宫内膜癌的II期临床试验关键性数据，预计将于2026年下半年公布。这一时间表为关注该疗法进展的投资者和医学界提供了明确的时间节点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNSE","FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110665123","title":"Sensei Biotherapeutics任命Anand Parikh为董事长、总裁兼首席执行官，自2026年6月12日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1110665123","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110665123?lang=zh_cn&edition=full","pubTime":"2026-06-15 20:11","pubTimestamp":1781525508,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics, Inc. (SNSE) 宣布，自2026年6月12日起，Anand Parikh将正式出任公司董事长、总裁兼首席执行官。此项任命标志着公司领导层的重要更迭。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FTH","SNSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139331227","title":"Sensei Biotherapeutics更名为Faeth Therapeutics，全力推进口服抗癌疗法Piktor","url":"https://stock-news.laohu8.com/highlight/detail?id=1139331227","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139331227?lang=zh_cn&edition=full","pubTime":"2026-06-15 20:10","pubTimestamp":1781525426,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics, Inc. 宣布将公司名称变更为Faeth Therapeutics。这一更名标志着公司战略重心聚焦于推进其核心候选药物Piktor的研发。Piktor是一种口服疗法，旨在靶向癌症中最常发生异常改变的信号通路之一。公司此举旨在更好地反映其专注于开发变革性癌症治疗药物的新方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","SNSE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123792949","title":"Sensei Biotherapeutics 在Piktor针对HR+/HER2-晚期乳腺癌的1B/2期试验中完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1123792949","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123792949?lang=zh_cn&edition=full","pubTime":"2026-05-05 19:31","pubTimestamp":1777980676,"startTime":"0","endTime":"0","summary":"生物技术公司Sensei Biotherapeutics, Inc. (SNSE) 宣布，其候选药物Piktor在针对HR阳性、HER2阴性（HR+/HER2-）晚期乳腺癌患者的1B/2期临床试验中，已完成对首位患者的给药。这一进展标志着该药物临床开发项目进入了新的阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150842099","title":"Sensei Biotherapeutics公司注册2490万股股票由售股股东转售 - 美国证监会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1150842099","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150842099?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:29","pubTimestamp":1777375757,"startTime":"0","endTime":"0","summary":"根据美国证监会最新文件披露，Sensei Biotherapeutics公司已正式注册2490万股普通股，这些股票将由售股股东进行二次转售。此次注册为现有股东提供了在公开市场出售其持股的通道，涉及股份数量较大，预计将对公司股票的市场流通性产生显著影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614070445","title":"Sensei Biotherapeutics, Inc.盘中异动 早盘股价大跌7.22%报31.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614070445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614070445?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:31","pubTimestamp":1772116305,"startTime":"0","endTime":"0","summary":"北京时间2026年02月26日22时31分，Sensei Biotherapeutics, Inc.股票出现波动，股价大幅下跌7.22%。截至发稿，该股报31.76美元/股，成交量4729股，换手率0.37%，振幅2.57%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.94%。Sensei Biotherapeutics, Inc.公司简介：Sensei Biotherapeutics Inc是一家专注于为癌症患者发现和开发下一代疗法的免疫肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602262231459542227a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602262231459542227a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNSE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614408418","title":"Sensei Biotherapeutics, Inc.盘中异动 早盘股价大涨5.73%报34.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614408418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614408418?lang=zh_cn&edition=full","pubTime":"2026-02-24 23:30","pubTimestamp":1771947010,"startTime":"0","endTime":"0","summary":"北京时间2026年02月24日23时30分，Sensei Biotherapeutics, Inc.股票出现异动，股价急速拉升5.73%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Moolec Science Sa C/Wts 30/01/2028、Edesa Biotech, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大，Cardio Diagnostics Holdings Inc.、Biorestorative Therapies, Inc.、Genprex, Inc.较为活跃，换手率分别为514.55%、279.30%、215.89%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Edesa Biotech, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为599.00%、43.38%、32.69%。Sensei Biotherapeutics, Inc.公司简介：Sensei Biotherapeutics Inc是一家专注于为癌症患者发现和开发下一代疗法的免疫肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224233010a4c3915f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224233010a4c3915f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNSE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612479965","title":"Eyepoint, Inc.盘中异动 下午盘大幅下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612479965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612479965?lang=zh_cn&edition=full","pubTime":"2026-02-19 02:24","pubTimestamp":1771439083,"startTime":"0","endTime":"0","summary":"北京时间2026年02月19日02时24分，Eyepoint, Inc.股票出现异动，股价大幅下跌5.03%。Eyepoint, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Sensei Biotherapeutics, Inc.、Cardio Diagnostics Holdings Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Moolec Science Sa、Sensei Biotherapeutics, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为893.96%、799.88%、412.95%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Sensei Biotherapeutics, Inc.、Moolec Science Sa，振幅分别为160.33%、108.11%、106.99%。Eyepoint, Inc.公司简介：EyePoint Inc专注于开发和商业化用于治疗严重视网膜疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021902244497a67785&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021902244497a67785&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0979878070.USD","AMDW","BK4614","LU0823421333.USD","BK4573","SNSE","BK4534","LU1852331112.SGD","LU1861558580.USD","LU1988902786.USD","LU2931357623.SGD","LU2458330243.SGD","LU0127658192.USD","IE00BMPRXN33.USD","BK4512","LU0889565916.HKD","LU0823434583.USD","LU0082616367.USD","LU0889565833.HKD","LU1803068979.SGD","LU0320765992.SGD","LU1951198990.SGD","BK4612","AMUU","LU1861559042.SGD","AMDY","LU1242518857.USD","LU1923623000.USD","BK4554","LU1880398471.USD","BK4585","BK4605","LU0109392836.USD","BK4139","LU1303367103.USD","BK4543","LU1989764664.SGD","LU0719512351.SGD","IE00B5949003.HKD","AMYY","LU0274383776.USD","AMDD","LU2264538146.SGD","AMDG","LU0109394709.USD","IE0004445239.USD","LU2360106780.USD","LU0642271901.SGD","LU2355687059.USD","DAMD","EYPT","IE0009356076.USD","BK4007","BK4532","LU2250418816.HKD","LU1064131342.USD","LU1316542783.SGD","LU1951200564.SGD","LU2089985449.USD","BK4529","LU0198837287.USD","LU0390134368.USD","LU0081259029.USD","LU2054465674.USD","BK4588","LU2458330169.SGD","IE00BMPRXR70.SGD","LU0823434740.USD","BK4566","LU2098885051.SGD","BK4141","LU1242518931.SGD","LU1880398554.USD","LU0056508442.USD","LU0823421416.USD","BK4575","AMDU"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2612040595","title":"Renovorx, Inc.盘中异动 下午盘股价大涨5.04%报1.029美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612040595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612040595?lang=zh_cn&edition=full","pubTime":"2026-02-19 02:22","pubTimestamp":1771438921,"startTime":"0","endTime":"0","summary":"北京时间2026年02月19日02时22分，Renovorx, Inc.股票出现波动，股价快速拉升5.04%。截至发稿，该股报1.029美元/股，成交量9.1045万股，换手率0.25%，振幅4.08%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219022202a4b1058c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219022202a4b1058c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNSE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612447964","title":"Orchestra Biomed Holdings, Inc.盘中异动 快速上涨5.21%报4.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612447964","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612447964?lang=zh_cn&edition=full","pubTime":"2026-02-18 22:37","pubTimestamp":1771425457,"startTime":"0","endTime":"0","summary":"北京时间2026年02月18日22时37分，Orchestra Biomed Holdings, Inc.股票出现异动，股价急速拉升5.21%。Orchestra Biomed Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Orchestra Biomed Holdings, Inc.公司简介：Orchestra BioMed Holdings Inc 是一家生物医学创新公司，通过风险共担和利益共享的合作伙伴关系，加速将高影响力技术推向患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602182237379541694c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602182237379541694c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNSE","BK4082","OBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612406701","title":"Wave Life Sciences Ltd.盘中异动 早盘大幅拉升5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612406701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612406701?lang=zh_cn&edition=full","pubTime":"2026-02-18 22:34","pubTimestamp":1771425265,"startTime":"0","endTime":"0","summary":"北京时间2026年02月18日22时34分，Wave Life Sciences Ltd.股票出现异动，股价快速上涨5.72%。Wave Life Sciences Ltd.股票所在的生物技术行业中，整体跌幅为0.45%。Wave Life Sciences Ltd.公司简介：WAVE Life Sciences Ltd 是一家临床阶段的生物技术公司，专注于释放 RNA 药物的广泛潜力，靶向核糖核酸 ，以改变人类健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021822342597a675a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021822342597a675a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4505","IE0009354923.USD","BK4588","BK4007","RNA","WVE","SNSE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612860424","title":"Cardio Diagnostics Holdings Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612860424","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612860424?lang=zh_cn&edition=full","pubTime":"2026-02-18 22:31","pubTimestamp":1771425111,"startTime":"0","endTime":"0","summary":"北京时间2026年02月18日22时31分，Cardio Diagnostics Holdings Inc.股票出现异动，股价大幅拉升5.04%。Cardio Diagnostics Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.48%。Cardio Diagnostics Holdings Inc.公司简介：Cardio Diagnostics Holdings Inc 是一家医疗技术公司，专注在开发和商业化基于表观遗传学的心血管疾病临床测试。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218223151a4b0900e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218223151a4b0900e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CDIO","SNSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612248984","title":"Surrozen Inc C/Wts 01/08/2031 (To Pur Com)盘中异动 股价大跌11.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612248984","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612248984?lang=zh_cn&edition=full","pubTime":"2026-02-18 22:31","pubTimestamp":1771425111,"startTime":"0","endTime":"0","summary":"北京时间2026年02月18日22时31分，Surrozen Inc C/Wts 01/08/2031 股票出现异动，股价大幅下挫11.76%。Surrozen Inc C/Wts 01/08/2031 股票所在的生物技术行业中，整体跌幅为0.48%。Surrozen Inc C/Wts 01/08/2031 公司简介：Surrozen Inc 是一家临床阶段的生物技术公司，致力于发现和开发候选药物，以选择性地调节 Wnt 通路——一种多种器官和组织中组织修复的关键介质。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218223151a7077617&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218223151a7077617&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SRZNW","BK4139","SNSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612427581","title":"Ac Immune Sa盘中异动 股价大跌10.65%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612427581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612427581?lang=zh_cn&edition=full","pubTime":"2026-02-18 22:31","pubTimestamp":1771425093,"startTime":"0","endTime":"0","summary":"北京时间2026年02月18日22时31分，Ac Immune Sa股票出现异动，股价快速下跌10.65%。截至发稿，该股报2.60美元/股，成交量3.8412万股，换手率0.04%，振幅3.78%。Ac Immune Sa股票所在的生物技术行业中，整体跌幅为0.48%。Ac Immune Sa公司简介：AC Immune SA 是一家临床阶段的生物制药公司，专注于神经退行性疾病的研究。公司的管线产品包括ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056以及其他产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218223133a70775cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218223133a70775cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNSE","BK4139","ACIU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612405912","title":"莫德纳盘中异动 早盘股价大涨6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612405912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612405912?lang=zh_cn&edition=full","pubTime":"2026-02-18 22:31","pubTimestamp":1771425070,"startTime":"0","endTime":"0","summary":"北京时间2026年02月18日22时31分，莫德纳股票出现异动，股价大幅拉升6.01%。截至发稿，该股报46.57美元/股，成交量110.469万股，换手率0.28%，振幅1.47%。莫德纳股票所在的生物技术行业中，整体跌幅为0.48%。莫德纳公司简介：莫德纳是一家商业阶段的生物技术公司，成立于 2010 年，并于 2018 年 12 月首次公开募股。截至 2025 年 8 月，莫德纳有 35 种 mRNA 开发候选药物处于临床研究中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218223110a7077586&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218223110a7077586&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","BK4534","BK4533","BK4568","BK4551","BK4548","BK4585","BK4501","SNSE","MRNA","BK4532"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2612547862","title":"Traws Pharma, Inc.盘中异动 大幅上涨5.36%报2.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612547862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612547862?lang=zh_cn&edition=full","pubTime":"2026-02-18 22:30","pubTimestamp":1771425059,"startTime":"0","endTime":"0","summary":"北京时间2026年02月18日22时30分，Traws Pharma, Inc.股票出现异动，股价快速上涨5.36%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家临床阶段的生物制药公司，致力于开发新型疗法，以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218223059a7077554&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218223059a7077554&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","SNSE","TRAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124000971","title":"Sensei Biotherapeutics宣布收购Faeth Therapeutics并完成2亿美元同步私募融资","url":"https://stock-news.laohu8.com/highlight/detail?id=1124000971","media":"美股速递","labels":["shareholding","corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124000971?lang=zh_cn&edition=full","pubTime":"2026-02-18 21:02","pubTimestamp":1771419777,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics, Inc.正式披露两项重大战略举措：公司已完成对Faeth Therapeutics的全面收购，同时成功实施规模达2亿美元的同步私募股权融资。此次交易将显著增强公司在肿瘤治疗领域的研发管线布局，私募资金将用于加速合并后实体的创新疗法开发与临床推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNSE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611816182","title":"Sensei Biotherapeutics, Inc.盘中异动 急速拉升5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611816182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611816182?lang=zh_cn&edition=full","pubTime":"2026-02-13 01:00","pubTimestamp":1770915606,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日01时00分，Sensei Biotherapeutics, Inc.股票出现异动，股价大幅拉升5.66%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Karyopharm Therapeutics Inc.、Briacell Therapeutics Corp C/Wts 涨幅较大，Onconetix, Inc.、Quince Therapeutics, Inc.、Biorestorative Therapies, Inc.较为活跃，换手率分别为349.14%、188.11%、89.48%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Polaryx Therapeutics, Inc.、Karyopharm Therapeutics Inc.，振幅分别为62.50%、60.77%、36.91%。Sensei Biotherapeutics, Inc.公司简介：Sensei Biotherapeutics Inc是一家专注于为癌症患者发现和开发下一代疗法的免疫肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602130100069540f0e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602130100069540f0e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610466224","title":"Sensei Biotherapeutics, Inc.盘中异动 早盘急速上涨7.20%报9.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610466224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610466224?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:45","pubTimestamp":1770648349,"startTime":"0","endTime":"0","summary":"北京时间2026年02月09日22时45分，Sensei Biotherapeutics, Inc.股票出现波动，股价大幅拉升7.20%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Lunai Bioworks Inc.、Alpha Tau Medical Ltd C/Wts 、Novabay Pharmaceuticals, Inc.涨幅较大，Agomab Therapeutics Nv、Liminatus Pharma, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为64.46%、33.74%、20.92%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Genenta Science Spa、Ernexa Therapeutics Inc.，振幅分别为34.95%、28.39%、23.92%。Sensei Biotherapeutics, Inc.公司简介：Sensei Biotherapeutics Inc是一家专注于为癌症患者发现和开发下一代疗法的免疫肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020922454995407721&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020922454995407721&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNSE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.senseibio.com","stockEarnings":[{"period":"1week","weight":0.0966},{"period":"1month","weight":-0.3221},{"period":"3month","weight":-0.5463},{"period":"6month","weight":0.5186},{"period":"1year","weight":1.1242},{"period":"ytd","weight":0.298}],"compareEarnings":[{"period":"1week","weight":0.018},{"period":"1month","weight":0.0151},{"period":"3month","weight":0.1344},{"period":"6month","weight":0.1092},{"period":"1year","weight":0.245},{"period":"ytd","weight":0.1003}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sensei Biotherapeutics, Inc.是一家临床阶段的免疫疗法公司，于2017年12月1日在特拉华州注册成立。该公司是一家免疫肿瘤学公司，专注于癌症患者下一代疗法的发现和开发。通过TMAb（肿瘤微环境激活生物制剂）平台，公司正在开发高选择性疗法，旨在在肿瘤微环境中选择性地禁用免疫抑制信号或激活免疫刺激信号，以释放T细胞对抗肿瘤。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.040355},{"month":2,"riseRate":0.6,"avgChangeRate":0.423412},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.06831},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.097622},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.09801},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.053796},{"month":7,"riseRate":0.4,"avgChangeRate":-0.061757},{"month":8,"riseRate":0.4,"avgChangeRate":0.038959},{"month":9,"riseRate":0.2,"avgChangeRate":-0.058884},{"month":10,"riseRate":0,"avgChangeRate":-0.117074},{"month":11,"riseRate":0.4,"avgChangeRate":-0.031651},{"month":12,"riseRate":0.4,"avgChangeRate":0.005246}],"exchange":"NASDAQ","name":"Sensei Biotherapeutics, Inc.","nameEN":"Sensei Biotherapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sensei Biotherapeutics, Inc.(SNSE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sensei Biotherapeutics, Inc.(SNSE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sensei Biotherapeutics, Inc.,SNSE,Sensei Biotherapeutics, Inc.股票,Sensei Biotherapeutics, Inc.股票老虎,Sensei Biotherapeutics, Inc.股票老虎国际,Sensei Biotherapeutics, Inc.行情,Sensei Biotherapeutics, Inc.股票行情,Sensei Biotherapeutics, Inc.股价,Sensei Biotherapeutics, Inc.股市,Sensei Biotherapeutics, Inc.股票价格,Sensei Biotherapeutics, Inc.股票交易,Sensei Biotherapeutics, Inc.股票购买,Sensei Biotherapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sensei Biotherapeutics, Inc.(SNSE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sensei Biotherapeutics, Inc.(SNSE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}